Cargando…

Prognostic factors affecting the outcome after allogeneic haematopoietic stem cell transplantation for myelodysplastic syndrome

In the present study, we retrospectively analysed the results of HSCT in 47 consecutive patients with MDS diagnosed at our department between 2002 and 2019, with a focus on possible predictive factors influencing overall survival (OS), the development of relapse, infections, and the occurrence of gr...

Descripción completa

Detalles Bibliográficos
Autores principales: Belohlavkova, P, Vrbacky, F, Smolej, L, Radocha, J, Lanska, M, Visek, B, Kupsa, T, Zavrelova, A, Zak, P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566995/
https://www.ncbi.nlm.nih.gov/pubmed/34760617
http://dx.doi.org/10.1016/j.lrr.2021.100274
_version_ 1784594138833879040
author Belohlavkova, P
Vrbacky, F
Smolej, L
Radocha, J
Lanska, M
Visek, B
Kupsa, T
Zavrelova, A
Zak, P
author_facet Belohlavkova, P
Vrbacky, F
Smolej, L
Radocha, J
Lanska, M
Visek, B
Kupsa, T
Zavrelova, A
Zak, P
author_sort Belohlavkova, P
collection PubMed
description In the present study, we retrospectively analysed the results of HSCT in 47 consecutive patients with MDS diagnosed at our department between 2002 and 2019, with a focus on possible predictive factors influencing overall survival (OS), the development of relapse, infections, and the occurrence of graft versus host disease (GvHD). In a univariate analysis, the pre-transplantation value of blasts in the marrow < 5% (p = 0.006), the revised International Prognostic Scoring System (IPSS-R) (p = 0.041), and karyotype (p = 0.009) were predictive of OS. Neither the elevation of serum ferritin (> 1000 ug/ml) nor increased C-reactive protein (CRP) (> 5 mg/l) was associated with shorter OS. In contrast, elevated serum lactate dehydrogenase (LDH) (> 213 U/l) was associated with shorter OS (p = 0.04).
format Online
Article
Text
id pubmed-8566995
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-85669952021-11-09 Prognostic factors affecting the outcome after allogeneic haematopoietic stem cell transplantation for myelodysplastic syndrome Belohlavkova, P Vrbacky, F Smolej, L Radocha, J Lanska, M Visek, B Kupsa, T Zavrelova, A Zak, P Leuk Res Rep Article In the present study, we retrospectively analysed the results of HSCT in 47 consecutive patients with MDS diagnosed at our department between 2002 and 2019, with a focus on possible predictive factors influencing overall survival (OS), the development of relapse, infections, and the occurrence of graft versus host disease (GvHD). In a univariate analysis, the pre-transplantation value of blasts in the marrow < 5% (p = 0.006), the revised International Prognostic Scoring System (IPSS-R) (p = 0.041), and karyotype (p = 0.009) were predictive of OS. Neither the elevation of serum ferritin (> 1000 ug/ml) nor increased C-reactive protein (CRP) (> 5 mg/l) was associated with shorter OS. In contrast, elevated serum lactate dehydrogenase (LDH) (> 213 U/l) was associated with shorter OS (p = 0.04). Elsevier 2021-10-18 /pmc/articles/PMC8566995/ /pubmed/34760617 http://dx.doi.org/10.1016/j.lrr.2021.100274 Text en © 2021 The Authors. Published by Elsevier Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Belohlavkova, P
Vrbacky, F
Smolej, L
Radocha, J
Lanska, M
Visek, B
Kupsa, T
Zavrelova, A
Zak, P
Prognostic factors affecting the outcome after allogeneic haematopoietic stem cell transplantation for myelodysplastic syndrome
title Prognostic factors affecting the outcome after allogeneic haematopoietic stem cell transplantation for myelodysplastic syndrome
title_full Prognostic factors affecting the outcome after allogeneic haematopoietic stem cell transplantation for myelodysplastic syndrome
title_fullStr Prognostic factors affecting the outcome after allogeneic haematopoietic stem cell transplantation for myelodysplastic syndrome
title_full_unstemmed Prognostic factors affecting the outcome after allogeneic haematopoietic stem cell transplantation for myelodysplastic syndrome
title_short Prognostic factors affecting the outcome after allogeneic haematopoietic stem cell transplantation for myelodysplastic syndrome
title_sort prognostic factors affecting the outcome after allogeneic haematopoietic stem cell transplantation for myelodysplastic syndrome
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566995/
https://www.ncbi.nlm.nih.gov/pubmed/34760617
http://dx.doi.org/10.1016/j.lrr.2021.100274
work_keys_str_mv AT belohlavkovap prognosticfactorsaffectingtheoutcomeafterallogeneichaematopoieticstemcelltransplantationformyelodysplasticsyndrome
AT vrbackyf prognosticfactorsaffectingtheoutcomeafterallogeneichaematopoieticstemcelltransplantationformyelodysplasticsyndrome
AT smolejl prognosticfactorsaffectingtheoutcomeafterallogeneichaematopoieticstemcelltransplantationformyelodysplasticsyndrome
AT radochaj prognosticfactorsaffectingtheoutcomeafterallogeneichaematopoieticstemcelltransplantationformyelodysplasticsyndrome
AT lanskam prognosticfactorsaffectingtheoutcomeafterallogeneichaematopoieticstemcelltransplantationformyelodysplasticsyndrome
AT visekb prognosticfactorsaffectingtheoutcomeafterallogeneichaematopoieticstemcelltransplantationformyelodysplasticsyndrome
AT kupsat prognosticfactorsaffectingtheoutcomeafterallogeneichaematopoieticstemcelltransplantationformyelodysplasticsyndrome
AT zavrelovaa prognosticfactorsaffectingtheoutcomeafterallogeneichaematopoieticstemcelltransplantationformyelodysplasticsyndrome
AT zakp prognosticfactorsaffectingtheoutcomeafterallogeneichaematopoieticstemcelltransplantationformyelodysplasticsyndrome